ATI RN
Pharmacology Across the Lifespan Questions
Question 1 of 5
Indicate the adrenomimetic agent, which activates both beta₁ and beta₂ adrenoreceptors:
Correct Answer: C
Rationale: In pharmacology, understanding the specificity of adrenomimetic agents is crucial for safe and effective patient care. In this scenario, the correct answer is C) Isoproterenol. Isoproterenol is a non-selective adrenomimetic agent that activates both beta₁ and beta₂ adrenoreceptors. Activation of beta₁ receptors leads to increased heart rate and contractility, while activation of beta₂ receptors causes bronchodilation and vasodilation. Option A) Dobutamine is a selective beta₁ adrenomimetic agent commonly used to increase cardiac output in conditions like heart failure. Option B) Salbutamol is a selective beta₂ adrenomimetic agent used for bronchodilation in conditions like asthma. Option D) Phenylephrine is an alpha adrenomimetic agent that causes vasoconstriction by acting on alpha adrenergic receptors. Educationally, understanding the selectivity of adrenomimetic agents is vital for prescribing the right medication based on the desired physiological effects. It also highlights the importance of considering receptor specificity when treating patients of different age groups, as pharmacological responses may vary across the lifespan due to age-related changes in receptor sensitivity and distribution.
Question 2 of 5
Isoproterenol is:
Correct Answer: D
Rationale: Isoproterenol is a nonselective beta receptor agonist, making option D the correct choice. Isoproterenol stimulates both beta₁ and beta₂ adrenergic receptors in the body. This pharmacological action results in effects such as increased heart rate, bronchodilation, and vasodilation. Option A, stating that isoproterenol is both an alpha- and beta-receptor agonist, is incorrect because isoproterenol primarily acts on beta receptors rather than alpha receptors. Option B, suggesting that isoproterenol is a beta₁-selective agonist, is inaccurate as isoproterenol affects both beta₁ and beta₂ receptors. Option C, indicating that isoproterenol is a beta₂-selective agonist, is also incorrect because isoproterenol stimulates both beta₁ and beta₂ receptors, not just beta₂ receptors. Educationally, understanding the pharmacological properties of isoproterenol is crucial for healthcare professionals, especially in scenarios requiring the use of beta receptor agonists. This knowledge helps in selecting appropriate medications for specific clinical conditions and in managing patient care effectively.
Question 3 of 5
Which of the following topical decongestant agents is an alpha₂-selective agonist?
Correct Answer: B
Rationale: The correct answer is B) Xylometazoline. Xylometazoline is an alpha₂-selective agonist, making it the appropriate topical decongestant agent for this question. As an alpha₂-selective agonist, xylometazoline acts specifically on alpha-2 adrenergic receptors, leading to vasoconstriction and reduced nasal congestion without significant systemic effects like increased blood pressure or heart rate. Now, let's discuss why the other options are incorrect: A) Phenylephrine is an alpha₁-selective agonist, not an alpha₂-selective agonist. C) Ephedrine is a mixed-acting sympathomimetic amine with effects on both alpha and beta receptors, not specific to alpha₂ receptors. D) Epinephrine is a non-selective adrenergic agonist, affecting both alpha and beta receptors, and is not alpha₂-selective like xylometazoline. In an educational context, understanding the selectivity of decongestant agents is crucial for pharmacology students and healthcare professionals. Knowing the specific receptor targets of these medications helps in selecting the most appropriate treatment based on desired effects and potential side effects. This knowledge is essential for safe and effective patient care across the lifespan.
Question 4 of 5
Indicate the beta₁-selective antagonist:
Correct Answer: B
Rationale: In pharmacology across the lifespan, understanding beta blockers is crucial. In this question, the correct answer is B) Metoprolol, a beta₁-selective antagonist. Metoprolol selectively blocks beta₁ adrenergic receptors, commonly used in conditions like hypertension, angina, and heart failure. This selectivity minimizes side effects compared to non-selective beta blockers like propranolol (option A), which can lead to bronchoconstriction and masking of hypoglycemia symptoms. Carvedilol (option C) is a non-selective beta blocker with additional alpha-blocking properties, beneficial in heart failure. Sotalol (option D) is a beta blocker with class III antiarrhythmic properties, used for treating arrhythmias, but not beta₁-selective. Understanding the selectivity of beta blockers is crucial in tailoring drug therapy based on patient conditions and comorbidities, making Metoprolol the most appropriate choice in this scenario.
Question 5 of 5
Alpha receptor blockage by phentolamine leads to:
Correct Answer: A
Rationale: Phentolamine is a non-selective alpha-adrenergic receptor antagonist. When alpha receptors are blocked by phentolamine, it leads to cardiac stimulation. This is because alpha receptors are primarily located in peripheral blood vessels, and their blockade results in vasodilation. As a compensatory mechanism, the body responds by increasing cardiac output to maintain blood pressure, hence leading to cardiac stimulation. Option B, vasoconstriction, is incorrect because alpha receptor blockage causes vasodilation, not vasoconstriction. Option C, bronchial relaxation, is incorrect because phentolamine primarily affects vascular alpha receptors, not bronchial receptors. Option D, rise in blood pressure, is a distractor as alpha receptor blockage actually leads to a decrease in blood pressure due to vasodilation. Understanding the effects of alpha receptor blockage by phentolamine is important in pharmacology across the lifespan. This knowledge is crucial for healthcare professionals in managing conditions like hypertensive emergencies, pheochromocytoma crisis, and local anesthesia complications. It also highlights the interconnectedness of the cardiovascular and autonomic nervous systems, emphasizing the need for a comprehensive understanding of pharmacological interventions.